175 related articles for article (PubMed ID: 15250453)
1. Less frequent Pap smears for low-risk women?
Sanders FN
S Afr Med J; 2004 Jun; 94(6):435-6. PubMed ID: 15250453
[No Abstract] [Full Text] [Related]
2. Adjunctive human papillomavirus DNA testing is a useful option in some clinical settings for disease risk assessment and triage of females with ASC-H Papanicolaou test results.
Bandyopadhyay S; Austin RM; Dabbs D; Zhao C
Arch Pathol Lab Med; 2008 Dec; 132(12):1874-81. PubMed ID: 19061283
[TBL] [Abstract][Full Text] [Related]
3. Human papilloma virus, papanicolaou smears, and the college female.
Moscicki AB
Pediatr Clin North Am; 2005 Feb; 52(1):163-77, ix. PubMed ID: 15748929
[TBL] [Abstract][Full Text] [Related]
4. Testing for human papillomavirus in women with abnormal pap smear results.
Sawaya GF; Smith-McCune K
JAMA; 2002 Sep; 288(11):1350-1; author reply 1351-2. PubMed ID: 12234220
[No Abstract] [Full Text] [Related]
5. Testing for human papillomavirus in women with abnormal pap smear results.
McCaffery KJ; Waller J; Forrest S; Wardle J
JAMA; 2002 Sep; 288(11):1350; author reply 1351-2. PubMed ID: 12234219
[No Abstract] [Full Text] [Related]
6. Cervical cancer screening and updated Pap guidelines.
Warren JB; Gullett H; King VJ
Prim Care; 2009 Mar; 36(1):131-49, ix. PubMed ID: 19231606
[TBL] [Abstract][Full Text] [Related]
7. Human papillomavirus (HPV) testing in the management of women with abnormal Pap smears. Experience of a colposcopy referral clinic.
Ciotti M; Sesti F; Paba P; Benedetto A; Patrizi L; Criscuolo A; Piccione E; Branca M; Syrjänen K; Favalli C
Eur J Gynaecol Oncol; 2004; 25(5):577-84. PubMed ID: 15493169
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of human papillomavirus testing in primary screening for cervical abnormalities: comparison of sensitivity, specificity, and frequency of referral.
Kulasingam SL; Hughes JP; Kiviat NB; Mao C; Weiss NS; Kuypers JM; Koutsky LA
JAMA; 2002 Oct; 288(14):1749-57. PubMed ID: 12365959
[TBL] [Abstract][Full Text] [Related]
9. Extended duration of the detectable stage by adding HPV test in cervical cancer screening.
van den Akker-van Marie ME; van Ballegooijen M; Rozendaal L; Meijer CJ; Habbema JD
Br J Cancer; 2003 Nov; 89(10):1830-3. PubMed ID: 14612887
[TBL] [Abstract][Full Text] [Related]
10. Screening for cervical cancer in high-risk populations: DNA pap test or Hybrid Capture II test alone?
Miranda Pereira SM; Castelo A; Makabe S; Utagawa ML; Di Loreto C; Sakamoto Maeda MY; Marques JA; Santoro CL; Filho AL; Das Dores GB
Int J Gynecol Pathol; 2006 Jan; 25(1):38-41. PubMed ID: 16306782
[TBL] [Abstract][Full Text] [Related]
11. Summaries for patients. Results of Pap smears and human papillomavirus tests during cervical cancer screening.
Ann Intern Med; 2008 Apr; 148(7):I32. PubMed ID: 18378942
[No Abstract] [Full Text] [Related]
12. [PCR and Digene Hybride Capture System I in identification of human papillomavirus].
Kwaśniewska A; Skoczyński M; Semczuk-Sikora A; Goździcka-Józefiak A
Ginekol Pol; 2001 Dec; 72(12A):1497-500. PubMed ID: 11883303
[TBL] [Abstract][Full Text] [Related]
13. Preventing cervical cancer globally by acting locally: if not now, when?
Gage JC; Castle PE
J Natl Cancer Inst; 2010 Oct; 102(20):1524-7. PubMed ID: 20884892
[No Abstract] [Full Text] [Related]
14. Benefits and costs of using HPV testing to screen for cervical cancer.
Mandelblatt JS; Lawrence WF; Womack SM; Jacobson D; Yi B; Hwang YT; Gold K; Barter J; Shah K
JAMA; 2002 May; 287(18):2372-81. PubMed ID: 11988058
[TBL] [Abstract][Full Text] [Related]
15. Contribution of human papillomavirus testing by hybrid capture in the triage of women with repeated abnormal pap smears before colposcopy referral.
Fait G; Kupferminc MJ; Daniel Y; Geva E; Ron IG; Lessing JB; Bar-Am A
Gynecol Oncol; 2000 Nov; 79(2):177-80. PubMed ID: 11063640
[TBL] [Abstract][Full Text] [Related]
16. Costs and benefits of different strategies to screen for cervical cancer in less-developed countries.
Mandelblatt JS; Lawrence WF; Gaffikin L; Limpahayom KK; Lumbiganon P; Warakamin S; King J; Yi B; Ringers P; Blumenthal PD
J Natl Cancer Inst; 2002 Oct; 94(19):1469-83. PubMed ID: 12359856
[TBL] [Abstract][Full Text] [Related]
17. Oncogenic human papillomavirus infection and cervical lesions in aboriginal women of Nunavut, Canada.
Healey SM; Aronson KJ; Mao Y; Schlecht NF; Mery LS; Ferenczy A; Franco EL
Sex Transm Dis; 2001 Dec; 28(12):694-700. PubMed ID: 11725224
[TBL] [Abstract][Full Text] [Related]
18. Evaluating the role of HPV testing for women with equivocal Papanicolaou test findings.
Cox JT
JAMA; 1999 May; 281(17):1645-7. PubMed ID: 10235161
[No Abstract] [Full Text] [Related]
19. Accuracy of HPV testing of vaginal smear obtained with a novel self-sampling device.
Stenvall H; Wikström I; Backlund I; Wilander E
Acta Obstet Gynecol Scand; 2007; 86(1):16-21. PubMed ID: 17230283
[TBL] [Abstract][Full Text] [Related]
20. HPV DNA testing for cervical cancer screening. FIGO 26th Annual Report on the Results of Treatment in Gynecological Cancer.
Wright TC
Int J Gynaecol Obstet; 2006 Nov; 95 Suppl 1():S239-46. PubMed ID: 17161163
[No Abstract] [Full Text] [Related]
[Next] [New Search]
